{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:18:52Z","timestamp":1792581532681,"version":"4.5.0"},"reference-count":139,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2022,11,1]]},"abstract":"<jats:sec id=\"ab-eoi220062-4\"><jats:title>Importance<\/jats:title><jats:p>Literature and anecdotal evidence suggest a relationship between male sex and retinopathy of prematurity (ROP). It is not known whether a difference, if present, is sex-related pathophysiologic predisposition or sex difference in meeting ROP screening criteria.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi220062-5\"><jats:title>Objective<\/jats:title><jats:p>To evaluate the association of sex with the development of treatment-warranted ROP.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi220062-6\"><jats:title>Data Sources<\/jats:title><jats:p>PubMed, Embase, and Web of Science databases were searched from 2000 to 2022. The search strategy used keywords including <jats:italic>retinopathy of prematurity or ROP or retrolental fibroplasia<\/jats:italic> and <jats:italic>treatment or anti-VEGF or bevacizumab or ranibizumab or aflibercept or conbercept or laser or cryotherapy<\/jats:italic> and <jats:italic>gender or sex or male or female<\/jats:italic> and medical subject headings terms.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi220062-7\"><jats:title>Study Selection<\/jats:title><jats:p>All studies reporting on treatment with anti\u2013vascular endothelial growth factor, laser photocoagulation, and\/or cryotherapy for ROP were identified. Studies reporting sex distribution in the treatment group were included in the meta-analysis. Exclusion criteria included case reports, case series of fewer than 10 treated patients, systematic reviews, conference abstracts, letters to the editor, animal studies, and non-English records.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi220062-8\"><jats:title>Data Extraction and Synthesis<\/jats:title><jats:p>Two reviewers independently screened and extracted the data following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The proportions of treated male and female infants were combined using random-effects meta-analysis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi220062-9\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Numbers and percentages of male and female infants treated for ROP.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi220062-10\"><jats:title>Results<\/jats:title><jats:p>Of 11\u202f368 identified studies, 316 met inclusion criteria, yielding a total of 31\u202f026 treated patients. A higher percentage of male infants were treated for ROP (55% [95% CI, 0.54%-0.55%]), with low heterogeneity between studies (<jats:italic>I<jats:sup>2<\/jats:sup><\/jats:italic>\u2009=\u200934%; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). Thirty-eight studies reported sex distribution in the screened population (170\u202f053 patients; 92\u202f612 [53%] male vs 77\u202f441 [47%] female). There was no significant difference in the odds of receiving treatment between screened male and female infants (pooled odds ratio, 1.04 [95% CI, 0.91-1.18]; <jats:italic>P<\/jats:italic>\u2009=\u2009.67).<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi220062-11\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>More male infants are treated for ROP than female infants. This could be due to a known relative pathophysiological fragility of preterm male infants in addition to a difference in ROP screening rates, with more male infants meeting the criteria than female infants. These findings have implications for future studies and may prompt more careful clinical monitoring of male neonates.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2022.3988","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T15:41:13Z","timestamp":1665070873000},"page":"1110","source":"Crossref","is-referenced-by-count":20,"title":["The Male to Female Ratio in Treatment-Warranted Retinopathy of Prematurity"],"prefix":"10.1001","volume":"140","author":[{"given":"Sandra","family":"Hoyek","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan L.","family":"Peacker","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Acaba-Berrocal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasenin","family":"Al-Khersan","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami Leonard M. Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Elizabeth","family":"Hartnett","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audina M.","family":"Berrocal","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami Leonard M. Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimesh A.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"eoi220062r1","first-page":"227","article-title":"Childhood blindness in the context of VISION 2020\u2013the right to sight.","volume":"79","author":"Gilbert","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"10","key":"eoi220062r2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/pch\/15.10.667","article-title":"Retinopathy of prematurity: Recommendations for screening.","volume":"15","author":"Jefferies","year":"2010","journal-title":"Paediatr Child Health"},{"key":"eoi220062r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2022.07.009","article-title":"Practice patterns and outcomes of intravitreal anti-VEGF injection for retinopathy of prematurity: an international multicenter study.","author":"Patel","year":"2022","journal-title":"Ophthalmology"},{"issue":"9","key":"eoi220062r4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/jama.1949.02900260018005","article-title":"Retrolental fibroplasia; incidence in different localities in recent years and a correlation of the incidence with treatment given the infants.","volume":"139","author":"Kinsey","year":"1949","journal-title":"JAMA"},{"issue":"11","key":"eoi220062r5","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1001\/jamaophthalmol.2013.5052","article-title":"Choroidal thickness in patients with a history of retinopathy of prematurity.","volume":"131","author":"Wu","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"eoi220062r6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.14744\/SEMB.2021.34966","article-title":"Evaluation of the effect of different treatment management on refractive outcomes in severe retinopathy of prematurity.","volume":"55","author":"Tiryaki Demir","year":"2021","journal-title":"Sisli Etfal Hastan Tip Bul"},{"issue":"6","key":"eoi220062r7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ophtha.2020.11.012","article-title":"Neurodevelopmental outcomes after bevacizumab treatment for retinopathy of prematurity: a meta-analysis.","volume":"128","author":"Tsai","year":"2021","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi220062r8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jaapos.2006.01.004","article-title":"Race, gender, and clinical risk index for babies (CRIB) score as predictors of severe retinopathy of prematurity.","volume":"10","author":"Yang","year":"2006","journal-title":"J AAPOS"},{"issue":"11","key":"eoi220062r9","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/s41372-019-0487-6","article-title":"Risk of development of treated retinopathy of prematurity in very low birth weight infants.","volume":"39","author":"Gonski","year":"2019","journal-title":"J Perinatol"},{"issue":"4","key":"eoi220062r10","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ophtha.2015.12.019","article-title":"Neonatal risk factors for treatment-demanding retinopathy of prematurity: a Danish national study.","volume":"123","author":"Slidsborg","year":"2016","journal-title":"Ophthalmology"},{"issue":"20","key":"eoi220062r11","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"eoi220062r12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"eoi220062r13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/ejos.ejos_39_20","article-title":"Evaluating peripheral retinal vascularization and rate of recurrence after intravitreal injection of ranibizumab as a primary treatment for retinopathy of prematurity.","volume":"113","author":"El Manhaly","year":"2021","journal-title":"J Egypt Ophthalmol Soc"},{"issue":"9","key":"eoi220062r14","doi-asserted-by":"publisher","first-page":"OCT550","DOI":"10.1167\/iovs.15-18583","article-title":"Retinal sequelae in adults treated with cryotherapy for retinopathy of prematurity.","volume":"57","author":"Nilsson","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi220062r15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000364809","article-title":"Structural, visual and refractive outcomes of intravitreal aflibercept injection in high-risk prethreshold type 1 retinopathy of prematurity.","volume":"53","author":"Salman","year":"2015","journal-title":"Ophthalmic Res"},{"issue":"6","key":"eoi220062r16","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/tropej\/fmt036","article-title":"Incidence and main risk factors for severe retinopathy of prematurity in infants weighing less than 1000 grams in Brazil.","volume":"59","author":"Fortes Filho","year":"2013","journal-title":"J Trop Pediatr"},{"issue":"1","key":"eoi220062r17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/eye.2009.63","article-title":"Long-term visual outcomes of laser-treated threshold retinopathy of prematurity: a study of refractive status at 7 years.","volume":"24","author":"Yang","year":"2010","journal-title":"Eye (Lond)"},{"issue":"8","key":"eoi220062r18","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.4103\/ijo.IJO_2581_20","article-title":"Combined intravitreal ranibizumab and zone I sparing laser ablation in infants with posterior zone I retinopathy of prematurity.","volume":"69","author":"Parchand","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"eoi220062r19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/09286586.2021.1894582","article-title":"Incidence, risk factors and screening evaluation of retinopathy of prematurity in high birthweight infants: a large cohort study in Turkey.","volume":"29","author":"Dericioglu","year":"2022","journal-title":"Ophthalmic Epidemiol"},{"issue":"3","key":"eoi220062r20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/ICB.0000000000000794","article-title":"Short-term computer-assisted quantification of plus disease after treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab or retinal laser photocoagulation.","volume":"15","author":"Cabrera","year":"2021","journal-title":"Retin Cases Brief Rep"},{"issue":"6","key":"eoi220062r21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1055\/s-0039-1700855","article-title":"Proportion of retinopathy of prematurity that was treated across regions in the United States.","volume":"38","author":"Cayabyab","year":"2021","journal-title":"Am J Perinatol"},{"issue":"11","key":"eoi220062r22","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1055\/s-0040-1710556","article-title":"Bevacizumab for retinopathy of prematurity: 2-year neurodevelopmental follow-up.","volume":"38","author":"Zayek","year":"2021","journal-title":"Am J Perinatol"},{"issue":"1","key":"eoi220062r23","first-page":"79","article-title":"Fluorescein angiography of retinal vascular involution after intravitreal injection of ranibizumab for retinopathy of prematurity.","volume":"12","author":"Cheng","year":"2019","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"eoi220062r24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/14767058.2017.1383379","article-title":"Propofol and fentanyl sedation for laser treatment of retinopathy of prematurity to avoid intubation.","volume":"32","author":"Piersigilli","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"eoi220062r25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00417-018-4162-y","article-title":"Foveal microvascular anomalies on optical coherence tomography angiography and the correlation with foveal thickness and visual acuity in retinopathy of prematurity.","volume":"257","author":"Chen","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"eoi220062r26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00417-018-4168-5","article-title":"Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity.","volume":"257","author":"Sukgen","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"eoi220062r27","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4565216","article-title":"Refractive and biometric outcomes in patients with retinopathy of prematurity treated with intravitreal injection of ranibizumab as compared with bevacizumab: a clinical study of correction at three years of age.","volume":"2018","author":"Chen","year":"2018","journal-title":"J Ophthalmol"},{"issue":"8","key":"eoi220062r28","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.oret.2017.11.012","article-title":"Analysis of the recurrence of plus disease after intravitreal ranibizumab as a primary monotherapy for severe retinopathy of prematurity.","volume":"2","author":"Ar\u00e1mbulo","year":"2018","journal-title":"Ophthalmol Retina"},{"issue":"2","key":"eoi220062r29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11845-017-1684-y","article-title":"Ultra-low dose of intravitreal bevacizumab in retinopathy of prematurity.","volume":"187","author":"Sahin","year":"2018","journal-title":"Ir J Med Sci"},{"issue":"3","key":"eoi220062r30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1001\/jamapediatrics.2017.4838","article-title":"Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial.","volume":"172","author":"Stahl","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"2","key":"eoi220062r31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaapos.2017.12.005","article-title":"Ocular complications following treatment in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.","volume":"22","author":"Morrison","year":"2018","journal-title":"J AAPOS"},{"issue":"2","key":"eoi220062r32","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1097\/IJG.0000000000000556","article-title":"The Effect of laser photocoagulation on intraocular pressure in premature infants with retinopathy of prematurity.","volume":"26","author":"Erginturk Acar","year":"2017","journal-title":"J Glaucoma"},{"issue":"2","key":"eoi220062r33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5301\/ejo.5000843","article-title":"Retinal and choroidal thickness in children with a history of retinopathy of prematurity and transscleral diode laser treatment.","volume":"27","author":"Sayman Muslubas","year":"2017","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"eoi220062r34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.7196\/SAMJ.2017.v107i3.11080","article-title":"The efficacy of intravitreal antivascular endothelial growth factor as primary treatment of retinopathy of prematurity: experience from a tertiary hospital.","volume":"107","author":"Kana","year":"2017","journal-title":"S Afr Med J"},{"issue":"3","key":"eoi220062r35","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1167\/iovs.16-20680","article-title":"Recurrence of retinopathy of prematurity after intravitreal ranibizumab monotherapy: timing and risk factors.","volume":"58","author":"Lyu","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"eoi220062r36","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.ophtha.2017.03.018","article-title":"Ranibizumab injection as primary treatment in patients with retinopathy of prematurity: anatomic outcomes and influencing factors.","volume":"124","author":"Huang","year":"2017","journal-title":"Ophthalmology"},{"key":"eoi220062r37","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5029278","article-title":"Combination of intravitreal injection of ranibizumab and photocoagulation for the treatment of aggressive posterior retinopathy of prematurity with vitreous hemorrhage.","volume":"2016","author":"Xu","year":"2016","journal-title":"J Ophthalmol"},{"issue":"1","key":"eoi220062r38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00417-015-2996-0","article-title":"Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab.","volume":"254","author":"Zhou","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"eoi220062r39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3109\/09273972.2016.1159232","article-title":"Evaluation of refractive errors and ocular biometric outcomes after intravitreal bevacizumab for retinopathy of prematurity.","volume":"24","author":"Gunay","year":"2016","journal-title":"Strabismus"},{"issue":"6","key":"eoi220062r40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jaapos.2016.08.008","article-title":"Prediction of severe retinopathy of prematurity using the screening algorithm WINROP in preterm infants.","volume":"20","author":"Ko\u00e7ak","year":"2016","journal-title":"J AAPOS"},{"issue":"2","key":"eoi220062r41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116669","article-title":"Time at treatment of severe retinopathy of prematurity in China: recommendations for guidelines in more mature infants.","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"eoi220062r42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3928\/23258160-20150323-04","article-title":"Spectral-domain optical coherence tomography of the macula in preterm infants treated with bevacizumab for retinopathy of prematurity.","volume":"46","author":"Dorta","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"eoi220062r43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3928\/01913913-20150326-12","article-title":"Spectral-domain OCT analyses of macular changes after ranibizumab therapy for type 1 retinopathy of prematurity.","volume":"52","author":"Erol","year":"2015","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"12","key":"eoi220062r44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144313","article-title":"Type 1 retinopathy of prematurity and its laser treatment of large preterm infants in East China.","volume":"10","author":"Shan","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"eoi220062r45","doi-asserted-by":"publisher","first-page":"340","DOI":"10.5935\/0004-2749.20150090","article-title":"Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity.","volume":"78","author":"Erol","year":"2015","journal-title":"Arq Bras Oftalmol"},{"issue":"9","key":"eoi220062r46","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/eye.2014.172","article-title":"Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes.","volume":"28","author":"Chen","year":"2014","journal-title":"Eye (Lond)"},{"issue":"10","key":"eoi220062r47","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1097\/IAE.0b013e31828e6969","article-title":"The use of digital imaging in the identification of skip areas after laser treatment for retinopathy of prematurity and its implications for education and patient care.","volume":"33","author":"Kang","year":"2013","journal-title":"Retina"},{"issue":"3","key":"eoi220062r48","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1136\/bjo.2011.203125","article-title":"No advanced retinopathy of prematurity stages 4 or 5 in a large high-risk German cohort.","volume":"96","author":"Muether","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"eoi220062r49","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.kjms.2012.04.026","article-title":"Neonatal intensive care unit-specific screening criteria for retinopathy of prematurity.","volume":"28","author":"Lai","year":"2012","journal-title":"Kaohsiung J Med Sci"},{"key":"eoi220062r50","first-page":"S15","article-title":"Combine intravitreal bevacizumab injection with laser treatment for aggressive posterior retinopathy of prematurity (AP-ROP).","volume":"94","author":"Wutthiworawong","year":"2011","journal-title":"J Med Assoc Thai"},{"issue":"9","key":"eoi220062r51","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00417-010-1375-0","article-title":"Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels.","volume":"248","author":"Lee","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"eoi220062r52","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"issue":"11","key":"eoi220062r53","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","article-title":"Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study.","volume":"92","author":"Kusaka","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"eoi220062r54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1600-0420.2005.00548.x","article-title":"Laser photocoagulation for retinopathy of prematurity: structural and functional outcome.","volume":"84","author":"Kieselbach","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"issue":"2","key":"eoi220062r55","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/sj.eye.6701437","article-title":"Severe retinopathy of prematurity: longitudinal observation of disease and screening implications.","volume":"19","author":"Ells","year":"2005","journal-title":"Eye (Lond)"},{"issue":"11","key":"eoi220062r56","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/sj.eye.6701729","article-title":"Argon laser photocoagulation for retinopathy of prematurity: long-term outcome.","volume":"19","author":"Ospina","year":"2005","journal-title":"Eye (Lond)"},{"issue":"2","key":"eoi220062r57","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/ceo.2004.32.issue-2","article-title":"Diode laser treatment of pre-threshold and threshold retinopathy of prematurity.","volume":"32","author":"Lee","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"eoi220062r58","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0008-4182(04)80142-X","article-title":"Myopia and astigmatism in retinopathy of prematurity after treatment with cryotherapy or laser photocoagulation.","volume":"39","author":"Al-Ghamdi","year":"2004","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"eoi220062r59","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3928\/23258160-20200228-07","article-title":"Functional and morphologic findings at four years after intravitreal bevacizumab or laser for type 1 ROP.","volume":"51","author":"Lepore","year":"2020","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"eoi220062r60","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/ceo.2004.32.issue-3","article-title":"Prospective randomized evaluation of diode-laser and cryotherapy in prethreshold retinopathy of prematurity.","volume":"32","author":"Azad","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"issue":"9","key":"eoi220062r61","doi-asserted-by":"publisher","first-page":"835","DOI":"10.4103\/ijo.IJO_872_16","article-title":"Refractive and ocular biometric profile of children with a history of laser treatment for retinopathy of prematurity.","volume":"65","author":"Kaur","year":"2017","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"eoi220062r62","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1590\/S1020-49892009000900005","article-title":"Prevalence of retinopathy of prematurity: an institutional cross-sectional study of preterm infants in Brazil.","volume":"26","author":"Fortes Filho","year":"2009","journal-title":"Rev Panam Salud Publica"},{"key":"eoi220062r63","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ajo.2021.06.034","article-title":"Cognitive outcomes following intravitreal bevacizumab for retinopathy of prematurity: 4- to 6-year outcomes in a prospective cohort.","volume":"234","author":"Chou","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"eoi220062r64","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3928\/01913913-20210707-01","article-title":"Refractive error profile of preterm infants at 1-year follow-up in a tertiary care hospital.","volume":"59","author":"Arora","year":"2022","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"11","key":"eoi220062r65","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.ophtha.2019.03.048","article-title":"Neurodevelopmental outcomes after intravitreal bevacizumab therapy for retinopathy of prematurity: a prospective case-control study.","volume":"126","author":"Fan","year":"2019","journal-title":"Ophthalmology"},{"issue":"18","key":"eoi220062r66","first-page":"112","article-title":"Incidence and risk factors of retinopathy of prematurity in Western India: report from a regional institute of ophthalmology.","volume":"9","author":"Vasavada","year":"2017","journal-title":"Nepal J Ophthalmol"},{"issue":"1","key":"eoi220062r67","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/IAE.0000000000000270","article-title":"Natural history of retinopathy of prematurity: two-year outcomes of a prospective study.","volume":"35","author":"Chen","year":"2015","journal-title":"Retina"},{"issue":"1","key":"eoi220062r68","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/02713683.2012.731550","article-title":"Associations of VEGF\/VEGF-receptor and HGF\/c-Met promoter polymorphisms with progression\/regression of retinopathy of prematurity.","volume":"38","author":"Kaya","year":"2013","journal-title":"Curr Eye Res"},{"issue":"13","key":"eoi220062r69","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.1167\/iovs.13-12297","article-title":"Screening for retinopathy of prematurity in China: a neonatal units-based prospective study.","volume":"54","author":"Xu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"eoi220062r70","doi-asserted-by":"crossref","DOI":"10.12996\/gmj.2013.31","article-title":"The risk factors for retinopathy of prematurity and need of laser photocoagulation: a single center experience.","volume":"24","author":"Kabatas","year":"2013","journal-title":"Gazi Med J"},{"issue":"9","key":"eoi220062r71","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.ophtha.2012.02.040","article-title":"Visual acuity, optical components, and macular abnormalities in patients with a history of retinopathy of prematurity.","volume":"119","author":"Wu","year":"2012","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi220062r72","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/09286586.2011.615449","article-title":"Screening for retinopathy of prematurity in a large tertiary neonatal intensive care unit in Turkey: frequency and risk factors.","volume":"18","author":"Sarikabadayi","year":"2011","journal-title":"Ophthalmic Epidemiol"},{"issue":"2","key":"eoi220062r73","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41433-021-01455-8","article-title":"DIGIROP efficacy for detecting treatment-requiring retinopathy of prematurity in a Portuguese cohort.","volume":"36","author":"Almeida","year":"2022","journal-title":"Eye (Lond)"},{"issue":"1","key":"eoi220062r74","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcjo.2021.02.030","article-title":"Retrospective comparison between growth and retinopathy of prematurity model versus WINROP model.","volume":"57","author":"Almeida","year":"2022","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"eoi220062r75","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s41598-021-80989-z","article-title":"Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007-2018 national health insurance claims data.","volume":"11","author":"Hong","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"eoi220062r76","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jcjo.2021.03.014","article-title":"Retinopathy of prematurity incidence and treatment modalities in moderate and late preterm infants: a study from two tertiary centers.","volume":"57","author":"\u00c7\u00f6mez","year":"2022","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"eoi220062r77","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5114\/ceji.2020.94789","article-title":"Inflammation-associated gene polymorphisms and clinical variables in the incidence and progression of retinopathy of prematurity.","volume":"45","author":"Szpecht","year":"2020","journal-title":"Cent Eur J Immunol"},{"issue":"1","key":"eoi220062r78","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamaophthalmol.2019.4502","article-title":"Individual risk prediction for sight-threatening retinopathy of prematurity using birth characteristics.","volume":"138","author":"Pivodic","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"eoi220062r79","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5152\/cjms.","article-title":"Effects of parent characteristics on the presence and the progression of retinopathy of prematurity.","volume":"4","author":"Kimyon","year":"2019","journal-title":"Cyprus J Med Sci"},{"key":"eoi220062r80","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ajo.2019.03.027","article-title":"retrospective validation of the postnatal growth and retinopathy of prematurity (G-ROP) criteria in a Japanese cohort.","volume":"205","author":"Shiraki","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"eoi220062r81","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jfo.2018.02.020","article-title":"Screening for retinopathy of prematurity by telemedicine in a tertiary level neonatal intensive care unit in France: review of a six-year period.","volume":"41","author":"Chan","year":"2018","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"eoi220062r82","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3345\/kjp.2015.58.2.52","article-title":"Postnatal weight gain in the first two weeks as a predicting factor of severe retinopathy of prematurity requiring treatment.","volume":"58","author":"Kim","year":"2015","journal-title":"Korean J Pediatr"},{"key":"eoi220062r83","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.3346\/jkms.2015.30.S1.S88","article-title":"Retinopathy of prematurity among very-low-birth-weight infants in Korea: incidence, treatment, and risk factors.","volume":"30","author":"Hwang","year":"2015","journal-title":"J Korean Med Sci"},{"key":"eoi220062r84","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/187929","article-title":"Association of maternal age to development and progression of retinopathy of prematurity in infants of gestational age under 33 weeks.","volume":"2014","author":"Uchida","year":"2014","journal-title":"J Ophthalmol"},{"key":"eoi220062r85","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.12659\/MSM.892262","article-title":"The incidence and risk factors of severe retinopathy of prematurity in extremely low birth weight infants in Turkey.","volume":"20","author":"Celebi","year":"2014","journal-title":"Med Sci Monit"},{"issue":"2","key":"eoi220062r86","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/ceo.2013.41.issue-2","article-title":"Treatment of retinopathy of prematurity in extremely premature infants over an 18-year period.","volume":"41","author":"Gunn","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"eoi220062r87","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jamaophthalmol.2013.566","article-title":"Efficacy of the screening algorithm WINROP in a Korean population of preterm infants.","volume":"131","author":"Choi","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"eoi220062r88","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00417-011-1648-2","article-title":"Effects of maternal and placental inflammation on retinopathy of prematurity.","volume":"250","author":"Woo","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"eoi220062r89","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/bjophthalmol-2012-301570","article-title":"Retinopathy of prematurity: are we missing any infant with retinopathy of prematurity?","volume":"96","author":"Amer","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"eoi220062r90","first-page":"113","article-title":"Incidence and risk factors for retinopathy of prematurity in the West Black Sea region, Turkey.","volume":"54","author":"Alpay","year":"2012","journal-title":"Turk J Pediatr"},{"issue":"12","key":"eoi220062r91","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1001\/archophthalmol.2012.2524","article-title":"The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model.","volume":"130","author":"Binenbaum","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"eoi220062r92","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jaapos.2010.07.012","article-title":"Comparison of UK and US screening criteria for detection of retinopathy of prematurity in a developing nation.","volume":"14","author":"Ugurbas","year":"2010","journal-title":"J AAPOS"},{"issue":"6","key":"eoi220062r93","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/archopht.123.6.825","article-title":"A population-based study on the visual outcome in 10-year-old preterm and full-term children.","volume":"123","author":"Larsson","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"eoi220062r94","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-021-01778-y","article-title":"Relationships between retinopathy of prematurity without ophthalmologic intervention and neurodevelopment and vision at 2 years.","author":"Brumbaugh","year":"2021","journal-title":"Pediatr Res"},{"issue":"8","key":"eoi220062r95","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.18240\/ijo","article-title":"Incidence and risk factors of retinopathy of prematurity and utility of the national screening criteria in a tertiary center in Iran.","volume":"12","author":"Khorshidifar","year":"2019","journal-title":"Int J Ophthalmol"},{"issue":"11","key":"eoi220062r96","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1136\/bjophthalmol-2014-304905","article-title":"Weight at first detection of retinopathy of prematurity predicts disease severity.","volume":"98","author":"Lundgren","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"eoi220062r97","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1136\/bjophthalmol-2016-310041","article-title":"International variations and trends in the treatment for retinopathy of prematurity.","volume":"101","author":"Darlow","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"eoi220062r98","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1542\/peds.2004-1309","article-title":"Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network.","volume":"115","author":"Darlow","year":"2005","journal-title":"Pediatrics"},{"issue":"2","key":"eoi220062r99","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3109\/02713683.2012.754902","article-title":"Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): four-years of screening with telemedicine.","volume":"38","author":"Fijalkowski","year":"2013","journal-title":"Curr Eye Res"},{"issue":"10","key":"eoi220062r100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109460","article-title":"Low birth weight is a risk factor for severe retinopathy of prematurity depending on gestational age.","volume":"9","author":"Lundgren","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"eoi220062r101","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12886-021-01952-0","article-title":"Validation of the DIGIROP-birth model in a Chinese cohort.","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"eoi220062r102","article-title":"Gender-related differences in care-seeking behaviour for newborns: a systematic review of the evidence in South Asia.","volume":"4","author":"Ismail","year":"2019","journal-title":"BMJ Glob Health"},{"key":"eoi220062r103","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41043-015-0014-0","article-title":"Sex differences in morbidity and care-seeking during the neonatal period in rural southern Nepal.","volume":"33","author":"Rosenstock","year":"2015","journal-title":"J Health Popul Nutr"},{"issue":"12","key":"eoi220062r104","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1136\/bjo.2005.073650","article-title":"Variation in rates of severe retinopathy of prematurity among neonatal intensive care units in the Australian and New Zealand Neonatal Network.","volume":"89","author":"Darlow","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"eoi220062r105","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010.","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"issue":"5","key":"eoi220062r106","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1542\/peds.2004-1180","article-title":"Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs.","volume":"115","author":"Gilbert","year":"2005","journal-title":"Pediatrics"},{"issue":"3","key":"eoi220062r107","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.clp.2019.05.011","article-title":"Achieved oxygenation saturations and outcome in extremely preterm infants.","volume":"46","author":"Stenson","year":"2019","journal-title":"Clin Perinatol"},{"key":"eoi220062r108","doi-asserted-by":"publisher","DOI":"10.29392\/001c.12346","article-title":"Neonatal oxygen therapy in low- and middle-income countries: a pragmatic review.","volume":"4","author":"Zelasko","year":"2020","journal-title":"J Glob Health Rep"},{"issue":"1","key":"eoi220062r109","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2020-000930","article-title":"ROP screening and treatment in four district-level special newborn care units in India: a cross-sectional study of screening and treatment rates.","volume":"5","author":"Sabherwal","year":"2021","journal-title":"BMJ Paediatr Open"},{"issue":"5","key":"eoi220062r110","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41433-019-0529-5","article-title":"Retinopathy of prematurity in Rwanda: a prospective multi-centre study following introduction of screening and treatment services.","volume":"34","author":"Mutangana","year":"2020","journal-title":"Eye (Lond)"},{"key":"eoi220062r111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2021.07.016","article-title":"Retinopathy of prematurity: advances in the screening and treatment of retinopathy of prematurity using a single center approach.","author":"Berrocal","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"eoi220062r112","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-005516","article-title":"Projecting sex imbalances at birth at global, regional and national levels from 2021 to 2100: scenario-based Bayesian probabilistic projections of the sex ratio at birth and missing female births based on 3.26 billion birth records.","volume":"6","author":"Chao","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"16","key":"eoi220062r113","doi-asserted-by":"publisher","first-page":"E2102","DOI":"10.1073\/pnas.1416546112","article-title":"The human sex ratio from conception to birth.","volume":"112","author":"Orzack","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"eoi220062r114","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/IJWH","article-title":"Fetal gender ratio in recurrent miscarriages.","volume":"3","author":"Del Fabro","year":"2011","journal-title":"Int J Womens Health"},{"issue":"2","key":"eoi220062r115","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0029-7844(96)00106-8","article-title":"Excess males in preterm birth: interactions with gestational age, race, and multiple birth.","volume":"88","author":"Cooperstock","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"2","key":"eoi220062r116","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/00324728.2020.1762912","article-title":"On the estimation of female births missing due to prenatal sex selection.","volume":"74","author":"Guilmoto","year":"2020","journal-title":"Popul Stud (Camb)"},{"issue":"2","key":"eoi220062r117","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/padr.2015.41.issue-2","article-title":"How many more missing women? excess female mortality and prenatal sex selection, 1970\u20132050.","volume":"41","author":"Bongaarts","year":"2015","journal-title":"Popul Dev Rev"},{"issue":"19","key":"eoi220062r118","doi-asserted-by":"publisher","first-page":"9303","DOI":"10.1073\/pnas.1812593116","article-title":"Systematic assessment of the sex ratio at birth for all countries and estimation of national imbalances and regional reference levels.","volume":"116","author":"Chao","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"eoi220062r119","first-page":"61","article-title":"More than 100 million women are missing.","volume":"37","author":"Sen","year":"1990","journal-title":"New York Rev Books"},{"issue":"3","key":"eoi220062r120","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/00324728.2015.1091603","article-title":"Mapping the diversity of gender preferences and sex imbalances in Indonesia in 2010.","volume":"69","author":"Guilmoto","year":"2015","journal-title":"Popul Stud (Camb)"},{"issue":"12","key":"eoi220062r121","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1503\/cmaj.101368","article-title":"The consequences of son preference and sex-selective abortion in China and other Asian countries.","volume":"183","author":"Hesketh","year":"2011","journal-title":"CMAJ"},{"issue":"9","key":"eoi220062r122","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/aogs.2016.95.issue-9","article-title":"Impact of fetal gender on the risk of preterm birth, a national cohort study.","volume":"95","author":"Peelen","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"eoi220062r123","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3109\/14767050903300969","article-title":"Fetal gender and pregnancy outcome.","volume":"23","author":"Melamed","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"eoi220062r124","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.ajog.2003.10.703","article-title":"Fetal sex and indicated very preterm birth: results of the EPIPAGE study.","volume":"190","author":"Zeitlin","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"6339","key":"eoi220062r125","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/bmj.285.6339.401","article-title":"Impact of sex ratio on onset and management of labour.","volume":"285","author":"Hall","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"7","key":"eoi220062r126","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/0002-9378(85)90361-8","article-title":"The influence of fetal sex on rupture of the membranes and preterm labor.","volume":"153","author":"MacGillivray","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"eoi220062r127","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1046\/j.1471-0528.2003.00022.x","article-title":"Gender aspects of preterm birth.","volume":"110","author":"Ingemarsson","year":"2003","journal-title":"BJOG"},{"issue":"1","key":"eoi220062r128","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12887-019-1713-2","article-title":"Newborn gender as a predictor of neonatal outcome in mixed gender twins born with very low birth weight.","volume":"19","author":"Barzilay","year":"2019","journal-title":"BMC Pediatr"},{"issue":"1","key":"eoi220062r129","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/s-2007-994668","article-title":"Fetal gender differences in preterm birth: findings in a North American cohort.","volume":"9","author":"McGregor","year":"1992","journal-title":"Am J Perinatol"},{"issue":"6","key":"eoi220062r130","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.ajog.2006.05.023","article-title":"The Alabama Preterm Birth Study: intrauterine infection and placental histologic findings in preterm births of males and females less than 32 weeks.","volume":"195","author":"Goldenberg","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"eoi220062r131","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.placenta.2009.11.010","article-title":"Review: sex and the human placenta: mediating differential strategies of fetal growth and survival.","volume":"31","author":"Clifton","year":"2010","journal-title":"Placenta"},{"issue":"2","key":"eoi220062r132","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.placenta.2012.11.007","article-title":"Fetal sex and preterm birth.","volume":"34","author":"Challis","year":"2013","journal-title":"Placenta"},{"key":"eoi220062r133","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fped.2017.00144","article-title":"Effect of fetal sex on maternal and obstetric outcomes.","volume":"5","author":"Al-Qaraghouli","year":"2017","journal-title":"Front Pediatr"},{"issue":"1","key":"eoi220062r134","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13293-020-00299-3","article-title":"Fetal sex and maternal pregnancy outcomes: a systematic review and meta-analysis.","volume":"11","author":"Broere-Brown","year":"2020","journal-title":"Biol Sex Differ"},{"issue":"1","key":"eoi220062r135","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.1038\/s41598-017-06490-8","article-title":"Gestational age-specific sex difference in mortality and morbidities of preterm infants: a nationwide study.","volume":"7","author":"Shim","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"eoi220062r136","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.9382","article-title":"Mortality and morbidity of infants born extremely preterm at tertiary medical centers in China from 2010 to 2019.","volume":"4","author":"Zhu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"eoi220062r137","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fped.2017.00006","article-title":"Gender differences in respiratory morbidity and mortality of preterm neonates.","volume":"5","author":"Townsel","year":"2017","journal-title":"Front Pediatr"},{"issue":"2","key":"eoi220062r138","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1542\/peds.78.2.238","article-title":"Discordance between male and female deaths due to the respiratory distress syndrome.","volume":"78","author":"Perelman","year":"1986","journal-title":"Pediatrics"},{"issue":"1","key":"eoi220062r139","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jpeds.2010.01.046","article-title":"A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity.","volume":"157","author":"Di Fiore","year":"2010","journal-title":"J Pediatr"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2797003\/jamaophthalmology_hoyek_2022_oi_220062_1668089428.82561.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T16:03:04Z","timestamp":1668700984000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2797003"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":139,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.3988","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,1]]}}}